Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,770,031
-$1,339,300 QoQ
Shares Held
574,011
-0.4% QoQ
Ownership
0.878%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Derivatives in ARVN
reported options exposure · as of Sep 30, 2025CallValue
$2,530,440
CallShares
297,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. ARVN ranks #169 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ARVN
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,770,031 | 574,011 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,109,331 | 576,352 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,936,970 | 1,259,441 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,160,848 | 2,131,555 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $2,530,440 | 297,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $13,969,809 | 1,898,072 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $1,759,040 | 239,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $9,198,488 | 1,310,326 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,035,540 | 314,843 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $2,108,700 | 110,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $492,600 | 20,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $5,138,433 | 208,625 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,329,297 | 200,199 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,058,573 | 243,667 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,768,743 | 358,813 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,264,414 | 828,127 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,080,816 | 406,157 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,662,856 | 243,882 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,982,058 | 57,938 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,552,574 | 124,805 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,049,326 | 119,965 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,381,167 | 258,264 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,002,762 | 158,300 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,773,638 | 70,256 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,801,484 | 127,292 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,938,742 | 120,102 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,522,552 | 276,964 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,180,500 | 50,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $2,657,801 | 112,571 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $280,998 | 8,378 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,385,647 | 108,825 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||